Faith forward to end the HIV epidemic by 2030
The HIV Biomedical Update was presented as part of the 2024 U.S. Conference on HIV/AIDS (USCHA) Interfaith Pre-Conference, Moving Faith Forward in the South to End the Epidemic. The session was presented by Dr. Louis Shakelford, Director of External Relations at the HIV Vaccines Trials Network (HVTN), and also featured Dr. Ulysses Burley, III who leads the HVTN Faith Initiative. It focused on advances in the search for an HIV vaccine and other biomedical HIV prevention advances.
The USCHA Faith Pre-Conference was presented by the U.S. HIV & AIDS Faith Coalition, comprised of people of faith, faith leaders, and people working in the HIV and AIDS response. The day-long, hybrid conference engages participants to discuss and develop strategies to access and strengthen the capacity of houses of worship and faith-based organizations in efforts to end the HIV epidemic. The focus of this conference was on the experiences of people in the Southern region of the U.S. and the role of faith in combating HIV-related stigma and discrimination in the South.
Organized by the U.S. HIV & AIDS Faith Coalition, with support from Gilead Sciences, the HIV Vaccine Trials Network, and the United Church of Christ.
Sign up to receive our newsletter.